Skip to content

DNTH

Dianthus Therapeutics, Inc.

Stock

$88.21−0.11 (−0.12%)Close Oct 2, 2026

Free cash flow, 2025
−$129M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$129M—
2024−$78M—
2023−$37M—
2022−$29M—
2021−$61M—
2020−$64M—
2019−$60M—
2018−$50M—
2017−$24M—
2016−$6.7M—